INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/GiftVerified data

Souza Marcio reported PRAX

Director, Chief Executive Officer · Praxis Precision Medicines, Inc. · Common Stock

Side
G
Value
—
Shares
400
Price
—
Executed
Dec 30, 2025
Disclosed
Dec 31, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 30 executedDec 31, 2025 disclosed

PRAX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
16/ 100 · ROUTINE
Methodology →
  • Transaction type+3 / 20

    Gift

  • Relative size+5 / 25

    No reported dollar value · 18.2% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · PRAX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    20
    Gilbert Ray Cisneros, Jr.DSelf
    PRAXPraxis Precision Medicines, Inc.
    Purchase
    		BUY$1,001 – $15KSep 29, 2026Oct 12, 2026
    traded Sep 29, 2026
    		+13dHOUSE PTR

    Evidence

    28
    Gilbert Ray Cisneros, Jr.DSelf
    PRAXPraxis Precision Medicines, Inc.
    Purchase
    		BUY$1,001 – $15KJul 30, 2026Sep 4, 2026
    traded Jul 30, 2026
    		+36dHOUSE PTR

    Evidence

    0
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M—
    3,034 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$309K
    999 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$544K
    1,750 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$890K
    2,854 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$314K
    1,004 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$158K
    504 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$403K
    1,279 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    19
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$264K
    837 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    0
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M—
    8,566 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    17
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M$379K
    8,566 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    13
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Option exercise · 10b5-1 plan
    		M$447K
    3,034 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    5
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$3,014
    10 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    5
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$36K
    120 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    8
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$98K
    320 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$210K
    683 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    15
    DJ
    DeSimone JillDirector
    PRAXPraxis Precision Medicines, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$382K
    1,240 sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    12
    ML
    Mastrocola LaurenPrincipal Accounting Officer
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$95K
    344 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    12
    SM
    Sniecinski MeganChief Operating Officer
    PRAXPraxis Precision Medicines, Inc.
    Tax withholding
    		F$244K
    885 sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001707657-25-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 30, 2025
    Published
    Dec 31, 2025
    Ingested by INSIDER
    Nov 5, 04:25 UTC
    Last re-read
    Nov 5, 04:25 UTC

    Extracted facts

    Filer
    Souza Marcio
    Role
    Director, Chief Executive Officer
    Transaction
    GiftAs filed: “G”
    Asset
    Praxis Precision Medicines, Inc.
    Ticker
    PRAX
    Shares
    400
    Price per share
    $0
    Execution date (reported)
    Dec 30, 2025
    Owned after transaction
    2,600 shares
    Days from execution to publication
    1

    What this establishes

    Souza Marcio filed this Form 4 reporting a gift of PRAX on Dec 30, 2025. It became public on Dec 31, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Chief Executive Officer
    Souza Marciocik:0001707657
    Issuer
    Praxis Precision Medicines, Inc.cik:0001689548

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.